Published in Immunol Allergy Clin North Am on August 01, 2015
Human genetic basis of interindividual variability in the course of infection. Proc Natl Acad Sci U S A (2015) 0.94
Eosinophilia. Prim Care (2016) 0.75
Primary immunodeficiencies associated with eosinophilia. Allergy Asthma Clin Immunol (2016) 0.75
Negative Regulation of Type 2 Immunity. Trends Immunol (2017) 0.75
Rho GTPases and the actin cytoskeleton. Science (1998) 28.19
Rho GTPases in cell biology. Nature (2002) 22.81
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet (2001) 15.27
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet (2005) 9.62
Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med (2006) 9.50
STAT3 mutations in the hyper-IgE syndrome. N Engl J Med (2007) 8.99
Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem (1995) 8.52
Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature (2008) 8.17
Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature (2007) 7.07
Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis (2004) 6.54
Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med (2005) 6.37
Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med (1999) 5.82
Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics (1954) 5.36
Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med (2009) 4.52
Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet (1995) 4.19
Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med (2010) 3.98
Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med (2010) 3.93
Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics (1972) 3.75
Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res (2012) 3.71
Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet (2002) 3.61
IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest (2010) 3.40
Job's Syndrome. Recurrent, "cold", staphylococcal abscesses. Lancet (1966) 3.27
Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol (2009) 3.13
Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr (1997) 2.92
Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA (2014) 2.89
Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet (2000) 2.85
Multiple phenotypes in phosphoglucomutase 1 deficiency. N Engl J Med (2014) 2.62
Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol (2014) 2.61
Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol (2008) 2.50
Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles. J Allergy Clin Immunol (2012) 2.47
Loeys-Dietz syndrome: a primer for diagnosis and management. Genet Med (2014) 2.46
A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr (1994) 2.39
Primary immune deficiencies with aberrant IgE production. J Allergy Clin Immunol (2008) 2.38
Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci U S A (2002) 2.32
Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol (2008) 2.18
Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood (2014) 2.17
A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity (2011) 2.15
Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood (1997) 2.10
TGFβ receptor mutations impose a strong predisposition for human allergic disease. Sci Transl Med (2013) 2.08
Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr (2004) 2.01
An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr (1982) 1.99
Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood (2014) 1.88
FOXP3 acts as a rheostat of the immune response. Immunol Rev (2005) 1.86
Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med (2014) 1.81
CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol (2006) 1.81
How I treat ADA deficiency. Blood (2009) 1.70
Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency. J Pediatr (2001) 1.67
Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines? Curr Opin Immunol (2010) 1.66
Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen. Pediatr Hematol Oncol (2012) 1.65
Omenn syndrome: inflammation in leaky severe combined immunodeficiency. J Allergy Clin Immunol (2008) 1.64
DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood (2012) 1.63
Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol (2007) 1.61
Netherton syndrome: a case report and review of the literature. Int J Dermatol (2006) 1.57
Characteristics and outcome of early-onset, severe forms of Wiskott-Aldrich syndrome. Blood (2012) 1.56
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol (2013) 1.55
Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome. J Allergy Clin Immunol (2013) 1.49
Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. Blood (2007) 1.49
Activation of Rho GTPases by DOCK exchange factors is mediated by a nucleotide sensor. Science (2009) 1.47
DOCK8 is essential for T-cell survival and the maintenance of CD8+ T-cell memory. Eur J Immunol (2011) 1.46
T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol (2005) 1.38
Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation. Bone Marrow Transplant (2010) 1.38
Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency. Clin Immunol (2011) 1.38
How I treat autoimmune lymphoproliferative syndrome. Blood (2011) 1.38
Clinical manifestations of hyper IgE syndromes. Dis Markers (2010) 1.37
A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood (2011) 1.36
Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation. Klin Padiatr (2010) 1.34
Amerioration of neurologic abnormalities after "enzyme replacement" in adenosine deaminase deficiency. N Engl J Med (1980) 1.32
DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients. J Clin Immunol (2015) 1.32
Hyper-IgE syndrome update. Ann N Y Acad Sci (2012) 1.31
Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant (2000) 1.30
Desmoglein as a target in skin disease and beyond. J Invest Dermatol (2011) 1.28
Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome. Dis Markers (2010) 1.28
Successful allogeneic hematopoietic stem cell transplantation for DOCK8 deficiency. J Allergy Clin Immunol (2011) 1.27
Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. J Allergy Clin Immunol (2014) 1.26
Wiskott-Aldrich syndrome: a comprehensive review. Ann N Y Acad Sci (2013) 1.25
Dedicator of cytokinesis 8 (DOCK8) deficiency. Curr Opin Allergy Clin Immunol (2010) 1.24
Successful engraftment of donor marrow after allogeneic hematopoietic cell transplantation in autosomal-recessive hyper-IgE syndrome caused by dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol (2010) 1.24
An update on the hyper-IgE syndromes. Arthritis Res Ther (2012) 1.23
Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation. J Allergy Clin Immunol (2013) 1.19
Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype. J Allergy Clin Immunol (2014) 1.19
Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting. Nat Genet (2013) 1.17
Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review. Leuk Lymphoma (2004) 1.17
The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet (2012) 1.16
Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol (2011) 1.14
Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. J Allergy Clin Immunol (2014) 1.13
Hyper IgE (Job's) syndrome: a primary immune deficiency with oral manifestations. Oral Dis (2008) 1.12
Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant (2009) 1.12
Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency. Biol Blood Marrow Transplant (2015) 1.12
Successful bone marrow transplantation for DOCK8 deficient hyper IgE syndrome. Pediatr Transplant (2012) 1.12
The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency. J Pediatr (1976) 1.08
Reviewing Omenn syndrome. Eur J Pediatr (2001) 1.07
Digestive histopathological presentation of IPEX syndrome. Mod Pathol (2008) 1.06
Warts and all: human papillomavirus in primary immunodeficiencies. J Allergy Clin Immunol (2012) 1.06
Genotype is an important determinant of phenotype in adenosine deaminase deficiency. Curr Opin Immunol (2003) 1.06
The face of Job. J Pediatr (1998) 1.05
Cranial synostosis in Job's syndrome. Lancet (1978) 1.04
Pneumocystis jiroveci infection in patients with hyper-immunoglobulin E syndrome. Pediatrics (2006) 1.04
Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol (2010) 1.03
Reduced memory B cells in patients with hyper IgE syndrome. Clin Immunol (2008) 1.03